SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-021082
Filing Date
2019-05-31
Accepted
2019-05-31 08:41:45
Documents
3
Period of Report
2019-05-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - FINANCIAL RELEASE tptx-8k_20190531.htm 8-K 34190
2 EX-99.1 tptx-ex991_6.htm EX-99.1 76399
3 GRAPHIC gsxq32huqln4000001.jpg GRAPHIC 5311
  Complete submission text file 0001564590-19-021082.txt   119439
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38871 | Film No.: 19868688
SIC: 2834 Pharmaceutical Preparations